Maynard Um
-
-
-
-
-
-
-
J&J presents new IMAAVY data for myasthenia gravis at EAN 2026
-
-
-
-
-
-
-
Johnson & Johnson reports positive results for rare blood disorder treatment
-
-
-
-
-
-
-
Johnson & Johnson survey finds bladder cancer treatments impact patient quality of life
-
-
-
-
-
-
-
Johnson & Johnson reports clinical trial results for robotic surgery system
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $266 at Guggenheim
-
-
-
-
-
-
-
Johnson & Johnson (JNJ) PT Raised to $265 at RBC Capital
-
-
-
-
-
-
-
Johnson & Johnson presents clinical data for TECNIS PureSee lens at ASCRS
-
416,466 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

